1. Home
  2. NRXP vs BANL Comparison

NRXP vs BANL Comparison

Compare NRXP & BANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • BANL
  • Stock Information
  • Founded
  • NRXP 2015
  • BANL 2015
  • Country
  • NRXP United States
  • BANL Malaysia
  • Employees
  • NRXP N/A
  • BANL N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • BANL Oil Refining/Marketing
  • Sector
  • NRXP Health Care
  • BANL Energy
  • Exchange
  • NRXP Nasdaq
  • BANL Nasdaq
  • Market Cap
  • NRXP 32.6M
  • BANL 25.3M
  • IPO Year
  • NRXP N/A
  • BANL 2023
  • Fundamental
  • Price
  • NRXP $3.05
  • BANL $0.85
  • Analyst Decision
  • NRXP Strong Buy
  • BANL
  • Analyst Count
  • NRXP 4
  • BANL 0
  • Target Price
  • NRXP $28.50
  • BANL N/A
  • AVG Volume (30 Days)
  • NRXP 188.0K
  • BANL 405.0K
  • Earning Date
  • NRXP 08-13-2025
  • BANL 09-11-2025
  • Dividend Yield
  • NRXP N/A
  • BANL N/A
  • EPS Growth
  • NRXP N/A
  • BANL N/A
  • EPS
  • NRXP N/A
  • BANL N/A
  • Revenue
  • NRXP N/A
  • BANL $592,517,545.00
  • Revenue This Year
  • NRXP N/A
  • BANL N/A
  • Revenue Next Year
  • NRXP N/A
  • BANL N/A
  • P/E Ratio
  • NRXP N/A
  • BANL N/A
  • Revenue Growth
  • NRXP N/A
  • BANL 35.93
  • 52 Week Low
  • NRXP $1.10
  • BANL $0.55
  • 52 Week High
  • NRXP $6.01
  • BANL $1.35
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 43.40
  • BANL 51.61
  • Support Level
  • NRXP $3.12
  • BANL $0.71
  • Resistance Level
  • NRXP $3.53
  • BANL $1.03
  • Average True Range (ATR)
  • NRXP 0.16
  • BANL 0.08
  • MACD
  • NRXP -0.07
  • BANL 0.00
  • Stochastic Oscillator
  • NRXP 3.92
  • BANL 42.30

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About BANL CBL International Limited

CBL International Ltd is a marine fuel logistics company that provides a one-stop solution for vessel refueling. In the bunkering industry, it is referred to as a bunkering facilitator. It facilitates vessel refueling between ship operators and local physical distributors/traders by purchasing marine fuel, including fossil fuel and alternative fuel, from its suppliers and arranging for the suppliers to deliver the fuel to the customers. The company's customer base comprises container liners, bulk carriers, and tankers. Geographically, the company generates a majority of its revenue from China, followed by Hong Kong, Malaysia, Singapore, South Korea, and other regions.

Share on Social Networks: